Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ctim.2021.102754 http://scihub22266oqcxt.onion/10.1016/j.ctim.2021.102754 34153446!8213518!34153446     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Complement+Ther+Med 2021 ; 60 (ä): 102754 Nephropedia Template TP {{tp|p=34153446|t=2021. A meta-analysis for Lianhua Qingwen on the treatment of Coronavirus disease 2019 (COVID-19) |pdf=|usr=}}{{34153446}} gab.com Text A meta-analysis for Lianhua Qingwen on the treatment of Coronavirus disease 2019 (COVID-19) JO: Complement Ther Med http://www.kidney.de/pget.php?&tw=1&pmid=34153446 #FOAvip BACKGROUND: Traditional Chinese medicine (TCM) has been proven to played a great important role on the treatment of COVID-19. As one of the drugs recommended in Chinese guidelines, Lianhua Qingwen Granules or Capsules (LQ) are widely used.This systematic review and meta-analysis amis to evaluate the clinical efficacy of LQ on the treatment of COVID-19. METHODS: Seven databases (PubMed, EMBASE, CENTRAL, CNKI, VIP, CBM and Wanfang) were searched to include all appropriate clinical trials that explore the efficacy of LQ on the treatment of COVID-19. RESULT: A total of 3 trials including 245 COVID-19 patients were eventually enrolled.Compared with the control group,the LQ group showed great significant difference on reducing the rate of clinical change to severe or critical condition[RR?=?0.38, 95 %CI (0.17,0.85), P?<?0.05]and the fever time (SMD =-0.57,95 %CI (-0.96,-0.17), P<0.05),as well as the significant improvement on the disappearance rate of the clinical symptoms: fever [RR?=?1.36,95 %CI (1.14,1.61), P?<?0.05],cough[RR?=?1.99,95 %CI (1.39,2.86), P?<?0.05],fatigue[RR?=?1.52,95 %CI (1.15,2.01), P?<?0.05] and anhelation [RR?=?4.18,95 %CI (1.99,8.81), P?<?0.05], but no significance on expectoration[RR?=?2.46,95 %CI (0.81,7.51), P?<?0.05]. CONCLUSION: The clinical application of LQ on the treatment of COVID-19 has significant efficacy in improving clinical symptoms and reducing the rate of clinical change to severe or critical condition. Nevertheless, due to the limited quantity and quality of the included studies, more and higher quality trials with more observational indicators are expected to be published. Twit Text FOAVip A meta-analysis for Lianhua Qingwen on the treatment of Coronavirus disease 2019 (COVID-19) ????Complement Ther Med http://www.kidney.de/pget.php?&tw=1&pmid=34153446 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34153446 #FOAvip English Wikipedia <ref>{{Cite pmid|34153446}}</ref> A meta-analysis for Lianhua Qingwen on the treatment of Coronavirus disease 2019 (COVID-19) #MMPMID34153446 Zhuang J; Dai X; Wu Q; Cai H; Fu X; Zhang W; Chen B Complement Ther Med 2021[Aug]; 60 (ä): 102754 PMID34153446show ga BACKGROUND: Traditional Chinese medicine (TCM) has been proven to played a great important role on the treatment of COVID-19. As one of the drugs recommended in Chinese guidelines, Lianhua Qingwen Granules or Capsules (LQ) are widely used.This systematic review and meta-analysis amis to evaluate the clinical efficacy of LQ on the treatment of COVID-19. METHODS: Seven databases (PubMed, EMBASE, CENTRAL, CNKI, VIP, CBM and Wanfang) were searched to include all appropriate clinical trials that explore the efficacy of LQ on the treatment of COVID-19. RESULT: A total of 3 trials including 245 COVID-19 patients were eventually enrolled.Compared with the control group,the LQ group showed great significant difference on reducing the rate of clinical change to severe or critical condition[RR?=?0.38, 95 %CI (0.17,0.85), P? |*SARS-CoV-2[MESH] |COVID-19/*therapy[MESH] |China/epidemiology[MESH] |Clinical Trials as Topic[MESH] |Drugs, Chinese Herbal/*therapeutic use[MESH] |Humans[MESH]A meta-analysis for Lianhua Qingwen on the treatment of Coronavirus di(epmc).pdf DeepDyve Pubget Overpricing